Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting
暂无分享，去创建一个
G. Bonamy | M. Derde | X. Pivot | F. Petrelli | C. Villanueva | G. Dzagnidze | S. Pradhan | L. Kaufman | J. Hii | P. Feyaerts | F. Deforce | Hwoei Fen Soo Hoo | Viriya Kaewkangsadan | D. Cox | M. A. Georgievich | V. Shamrai | Lipatov O Nikolaevich | Jamie Kim | L. Jaison